We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Truvic Medical, Inc., a wholly-owned subsidiary of Imperative Care, Inc., today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the
Bengaluru headquartered PhableCare, India’s largest chronic disease management company, has raised Series B funding of INR 187 crores (USD 25 Million) within one year of raising Series A.
RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced Artificial Intelligence (AI) and computer vision solutions, today announces a new tool for prostate MRI
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, and
Arch Therapeutics, Inc., a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced it has entered into a distribution agreement with Centurion Therapeutics Inc.
DexCom, a developer of glucose monitoring systems for diabetes management, has received CE Mark for its Dexcom G7 continuous glucose monitoring (CGM) system indicated for people with diabetes
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Collaboration Live has received expansion of its U.S. Food & Drug Administration 510(k)
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, today announced new data further demonstrating the performance of DecisionDx-Melanoma and i31-SLNB to provide
BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today a partnership with the global biopharmaceutical company, UCB, to develop